Atrium Therapeutics, Inc. · NASDAQ:RNA
Winslow Brendan R. had 6,742 Atrium Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Sep 18, 2026 · Filed Sep 22, 2026
On Sep 18, 2026, Winslow Brendan R. (Chief Financial Officer) had 6,742 Atrium Therapeutics, Inc. shares withheld for tax at US$8.95 for US$60,341, leaving 36,859 shares. Filed Sep 22, 2026 (Form 4).
- Withheld for tax
- 6,742 shares
- Price
- US$8.95
- Value
- US$60,341
- Holding after
- 36,859 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | Shares withheld for tax | 6,742 | US$8.95 | 36,859 | Direct |
Source
Related
- Atrium Therapeutics, Inc.
- Winslow Brendan R.
- Atrium Therapeutics, Inc. shareholders
- Form 4 · Winslow Brendan R. · Apr 22, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026